DK1786913T3 - Fremgangsmåde til fremstilling af diarylcycloalkylderivater - Google Patents

Fremgangsmåde til fremstilling af diarylcycloalkylderivater

Info

Publication number
DK1786913T3
DK1786913T3 DK05782434.4T DK05782434T DK1786913T3 DK 1786913 T3 DK1786913 T3 DK 1786913T3 DK 05782434 T DK05782434 T DK 05782434T DK 1786913 T3 DK1786913 T3 DK 1786913T3
Authority
DK
Denmark
Prior art keywords
preparation
diarylcycloalkyl derivatives
diarylcycloalkyl
derivatives
Prior art date
Application number
DK05782434.4T
Other languages
Danish (da)
English (en)
Inventor
Christophe Salagnad
Frank Zocher
Andreas Burgard
Bernd Junker
Rolf Hoerlein
Thomas Stuedemann
Jochen Hachtel
Wolfgang Holla
Christoph Tappertzhofen
Berndt Kulitzscher
Stephane Mutti
Claus-Juergen Maier
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1786913T3 publication Critical patent/DK1786913T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/03—Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/62—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK05782434.4T 2004-08-23 2005-08-23 Fremgangsmåde til fremstilling af diarylcycloalkylderivater DK1786913T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004040736A DE102004040736B4 (de) 2004-08-23 2004-08-23 Verfahren zur Herstellung von Diarylcycloalkylderivaten
PCT/EP2005/009095 WO2006021420A2 (de) 2004-08-23 2005-08-23 Verfahren zur herstellung von diarylcycloalkylderivaten

Publications (1)

Publication Number Publication Date
DK1786913T3 true DK1786913T3 (da) 2011-11-28

Family

ID=35745474

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05782434.4T DK1786913T3 (da) 2004-08-23 2005-08-23 Fremgangsmåde til fremstilling af diarylcycloalkylderivater

Country Status (27)

Country Link
US (2) US7803950B2 (cg-RX-API-DMAC7.html)
EP (1) EP1786913B1 (cg-RX-API-DMAC7.html)
JP (1) JP4991543B2 (cg-RX-API-DMAC7.html)
KR (1) KR20070048741A (cg-RX-API-DMAC7.html)
CN (1) CN101014714B (cg-RX-API-DMAC7.html)
AR (1) AR053760A1 (cg-RX-API-DMAC7.html)
AT (1) ATE520785T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005276642B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0514000A (cg-RX-API-DMAC7.html)
CA (1) CA2578342A1 (cg-RX-API-DMAC7.html)
CY (1) CY1112080T1 (cg-RX-API-DMAC7.html)
DE (1) DE102004040736B4 (cg-RX-API-DMAC7.html)
DK (1) DK1786913T3 (cg-RX-API-DMAC7.html)
ES (1) ES2371762T3 (cg-RX-API-DMAC7.html)
IL (1) IL181339A0 (cg-RX-API-DMAC7.html)
MA (1) MA28796B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007001872A (cg-RX-API-DMAC7.html)
NO (1) NO20071316L (cg-RX-API-DMAC7.html)
NZ (1) NZ553602A (cg-RX-API-DMAC7.html)
PL (1) PL1786913T3 (cg-RX-API-DMAC7.html)
PT (1) PT1786913E (cg-RX-API-DMAC7.html)
RU (1) RU2414459C2 (cg-RX-API-DMAC7.html)
SI (1) SI1786913T1 (cg-RX-API-DMAC7.html)
TW (1) TW200621734A (cg-RX-API-DMAC7.html)
UY (1) UY29082A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006021420A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700635B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
CN101381302B (zh) * 2007-09-07 2013-04-03 上海睿智化学研究有限公司 2-溴甲基-6-甲基苯甲酰氯/溴的制备方法
CA2710538A1 (en) * 2008-01-25 2009-07-30 Xenoport, Inc. Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728899A (en) * 1995-03-27 1998-03-17 Hoechst Marion Roussel Inc. Preparation of cis-4-O-protected-2-cyclopentenol derivatives
BR0212158A (pt) * 2001-08-31 2004-07-13 Aventis Pharma Gmbh Derivados de diarilcicloalquila, processos para a sua preparação e sua aplicação como ativadores de ppar
US6884812B2 (en) * 2001-08-31 2005-04-26 Aventis Pharma Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
WO2003072100A1 (en) * 2002-02-25 2003-09-04 Eli Lilly And Company Peroxisome proliferator activated receptor modulators
DE10308353A1 (de) * 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7094795B2 (en) * 2003-02-27 2006-08-22 Sanofi-Aventis Deutschland Gmbh Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives
DE10308350B4 (de) * 2003-02-27 2006-06-01 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 1,3-Cyclohexandiol-Derivaten
WO2005040394A1 (fr) * 2003-10-22 2005-05-06 Rhodia Chimie Procede de fabrication de compose comprenant un groupement hydroxyle libre et un groupement hydroxyle protégé par une fonction ester par reaction enzymatique
DE102004038403B4 (de) * 2004-08-07 2006-08-31 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten

Also Published As

Publication number Publication date
SI1786913T1 (sl) 2011-12-30
WO2006021420A2 (de) 2006-03-02
KR20070048741A (ko) 2007-05-09
US20080051583A1 (en) 2008-02-28
JP2008510761A (ja) 2008-04-10
AR053760A1 (es) 2007-05-23
ATE520785T1 (de) 2011-09-15
DE102004040736A1 (de) 2006-03-02
UY29082A1 (es) 2006-03-31
DE102004040736B4 (de) 2007-01-11
EP1786913B1 (de) 2011-08-17
AU2005276642A1 (en) 2006-03-02
MX2007001872A (es) 2007-04-24
EP1786913A2 (de) 2007-05-23
BRPI0514000A (pt) 2008-05-20
WO2006021420A3 (de) 2006-12-21
NO20071316L (no) 2007-05-22
US7803950B2 (en) 2010-09-28
RU2414459C2 (ru) 2011-03-20
CA2578342A1 (en) 2006-03-02
ZA200700635B (en) 2010-01-27
NZ553602A (en) 2010-04-30
ES2371762T3 (es) 2012-01-09
MA28796B1 (fr) 2007-08-01
PT1786913E (pt) 2011-10-31
PL1786913T3 (pl) 2012-01-31
RU2007110644A (ru) 2008-09-27
IL181339A0 (en) 2007-07-04
CN101014714B (zh) 2012-05-23
TW200621734A (en) 2006-07-01
WO2006021420B1 (de) 2007-02-08
JP4991543B2 (ja) 2012-08-01
AU2005276642B2 (en) 2011-12-22
US20070197614A1 (en) 2007-08-23
CY1112080T1 (el) 2015-11-04
CN101014714A (zh) 2007-08-08

Similar Documents

Publication Publication Date Title
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2046767T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK1637610T3 (da) Fremgangsmåde til fremstilling af alkylestere
DK2094676T3 (da) Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater
DK1802579T3 (da) Derivater af 3-arylaminopyridin
DK1611108T3 (da) Fremgangsmåde til fremstilling af telmisartan
DK2141204T3 (da) Fremgangsmåde til fremstilling af bituminøse sammensætninger
DK1737461T3 (da) Carbolin-derivater til inhibering af angiogenese
DK1830956T3 (da) Fremgangsmåde til forberedelse af katalytiske materialer
NO20076030L (no) Fremgangsmåte for fremstilling av hydroklorsilaner
DK1852430T3 (da) Fremgangsmåde til fremstilling af proanthocyanidinoligomer
DK3029040T3 (da) Fremgangsmåde til fremstilling af chirale 8-(3-amino-piperidin-1-yl)-xanthiner
DK1813678T3 (da) Fremgangsmåde til fremstilling af glycogen
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
DK1682541T3 (da) Fremgangsmåde til fremstilling af tiotropiumsalte
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1727782T3 (da) Fremgangsmåde til fremstilling af aminophenolforbindelser
DK1963251T3 (da) Fremgangsmåde til fremstilling af aminer
DK1784183T3 (da) Fremgangsmåder til fremstilling af isothiazolderivater